Preoperative positron emission tomography/computed tomography predicts advanced Lymph node metastasis in esophageal squamous cell carcinoma patients

World Journal of Surgery

Volumn 35, Issue 6, 2011, Pages 1321-1326

  Hsu, Po Kuei ^a,b,c   Lin, Ko Han ^b   Wang, Shyh Jen ^b   Huang, Chien Sheng ^b,c   Wu, Yu Chung ^b,c   Hsu, Wen Hu ^b,c  

^a Chutung Veterans Hospital   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYSIS OF VARIANCE; ARTICLE; CANCER STAGING; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; METASTASIS; METHODOLOGY; MORTALITY; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; RADIOGRAPHY; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCINTISCANNING; SQUAMOUS CELL CARCINOMA; STATISTICS; SURVIVAL;

ANALYSIS OF VARIANCE; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; ROC CURVE; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79956039237     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-011-1081-z     Document Type: Article

References (22)

1. IC Wu CY Lu FC Kuo, et al. 2006 Interaction between cigarette, alcohol and betel nut use on esophageal cancer risk in Taiwan Eur J Clin Invest 36 236 241 16620285 10.1111/j.1365-2362.2006.01621.x 1:STN:280:DC%2BD283hsFSisw%3D%3D
2. A Jemal R Siegel E Ward, et al. 2009 Cancer statistics, 2009 CA Cancer J Clin 59 225 249 19474385 10.3322/caac.20006
3. LS Wang KC Chow KH Chi, et al. 1999 Prognosis of esophageal squamous cell carcinoma: analysis of clinicopathological and biological factors Am J Gastroenterol 94 1933 1940 10406262 10.1111/j.1572-0241.1999.01233.x 1:STN:280:DyaK1Mzjt1yqtw%3D%3D (Pubitemid 29315913)
4. CS Lin SC Chang YH Wei, et al. 2009 Prognostic variables in thoracic esophageal squamous cell carcinoma Ann Thorac Surg 87 1056 1065 19324127 10.1016/j.athoracsur.2008.11.051
5. WH Hsu PK Hsu CC Hsieh, et al. 2009 The metastatic lymph node number and ratio are independent prognostic factors in esophageal cancer J Gastrointest Surg 13 1913 1920 19672664 10.1007/s11605-009-0982-8
6. Edge SB, Byrd DR, Compton CC et al (2010) American Joint Committee on Cancer (AJCC) cancer staging manual, 7th edn. AJCC, Chicago
7. PK Hsu YC Wu TY Chou, et al. 2010 Comparison of the 6th and 7th editions of the American Joint Committee on Cancer tumor-node-metastasis staging system in patients with resected esophageal carcinoma Ann Thorac Surg 89 1024 1031 20338302 10.1016/j.athoracsur.2010.01.017
8. SR Puli JB Reddy ML Bechtold, et al. 2008 Staging accuracy of esophageal cancer by endoscopic ultrasound: a meta-analysis and systemic review World J Gastroenterol 14 1479 1490 18330935 10.3748/wjg.14.1479 (Pubitemid 351460159)
9. RJ Cerfolio AS Bryant 2006 Maximum standardized uptake values on positron emission tomography of esophageal cancer predicts stage, tumor biology, and survival Ann Thorac Surg 82 391 395 16863735 10.1016/j.athoracsur.2006.03.045 (Pubitemid 44080040)
10. WH Hsu PK Hsu SJ Wang, et al. 2009 Positron emission tomography-computed tomography in predicting locoregional invasion in esophageal squamous cell carcinoma Ann Thorac Surg 87 1564 1568 19379906 10.1016/j.athoracsur.2009.02.065
11. H Kato H Kuwano M Nakajima, et al. 2002 Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma Cancer 94 921 928 11920459 10.1002/cncr.10330 (Pubitemid 34150845)
12. SG Swisher M Maish JJ Erasmus, et al. 2004 Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer Ann Thorac Surg 78 1152 1160 15464463 10.1016/j.athoracsur.2004.04.046 (Pubitemid 39303827)
13. P Flamen A Lerut E Van Cutsen, et al. 2000 The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer J Thorac Cardiovasc Surg 120 1085 1092 11088030 10.1067/mtc.2000.110464 1:STN:280:DC%2BD3M%2FntF2ntA%3D%3D
14. JL Port PC Lee RJ Korst, et al. 2007 PET scanning predicts survival after induction chemotherapy for esophageal carcinoma Ann Thorac Surg 84 393 400 17643605 10.1016/j.athoracsur.2007.03.094 (Pubitemid 47079022)
15. 18F-fluorodeoxyglucose positron emission tomography to predict survival in patients with operable esophageal cancer Cancer 115 3196 3203 19472406 10.1002/cncr.24399
16. SG Little TW Rice B Bybel, et al. 2007 Is FDG-PET indicated for superficial esophageal cancer? Eur J Cardiothorac Surg 31 791 796 17337344 10.1016/j.ejcts.2007.01.037 (Pubitemid 46528719)
17. EP Van Vliet MH Heijenbrok-Kal MG Hunink, et al. 2008 Staging investigations for esophageal cancer: a meta-analysis Br J Cancer 98 547 557 18212745 10.1038/sj.bjc.6604200 (Pubitemid 351214529)
18. D Hong S Lunagomez EE Kim, et al. 2005 Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma Cancer 104 1620 1626 16118804 10.1002/cncr.21356 (Pubitemid 41437424)
19. C Cheze-Le Rest JP Metges P Teyton, et al. 2008 Prognostic value of initial fluorodeoxyglucose-PET in esophageal cancer: a prospective study Nucl Med Commun 29 628 635 18528185 10.1097/MNM.0b013e3282f81423 1:CAS:528: DC%2BD1cXms1yjtro%3D
20. 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer J Clin Oncol 22 3805 3812 15365078 10.1200/JCO.2004.01.083 (Pubitemid 41095222)
21. RN Williams SS Ubhi CD Sutton, et al. 2009 The early use of PET-CT alters the management of patients with esophageal cancer J Gastrointest Surg 13 868 873 19184245 10.1007/s11605-009-0812-z 1:STN:280:DC%2BD1M3ntFGlsw%3D%3D
22. JB Roedl DV Sahano RR Colen, et al. 2008 Tumor length measured on PET-CT predicts the most appropriate stage-dependent therapeutic approach in esophageal cancer Eur Radiol 18 2833 3284 18651155 10.1007/s00330-008-1078-7